RecruitingPhase 4NCT06294990

Klinefelter Syndrome and Testosterone Treatment in Puberty

Klinefelter Syndrome - the Effect of Testosterone Treatment in Puberty. a Randomized, Double-blind Placebo-controlled Intervention Study: 'The TiPY Study'


Sponsor

Lise Aksglæde

Enrollment

32 participants

Start Date

Aug 15, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this randomized clinical trial is to study the effect of testosterone replacement therapy during puberty in boys with Klinefelter syndrome (KS, 47,XXY). The main questions to answer are how treatment with testosterone will affect body fat mass, lipid and glucose metabolism, growth and body proportions, bone mineralization as well as effects on neurocognitive development and emotional and social difficulties. Participants will be randomized to two years treatment with testosterone or placebo.


Eligibility

Sex: MALEMin Age: 10 YearsMax Age: 14 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Placebo and a drug called Testosterone gel for people with klinefelter syndrome. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGTestosterone gel

Two years treatment with testosterone

OTHERPlacebo

Two years treatment with placebo


Locations(1)

Copenhagen University Hospital, Rigshospitalet

Copenhagen, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06294990


Related Trials